Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Current Leases (2019 - 2025)

Acro Biomedical has reported Current Leases over the past 7 years, most recently at $13651.0 for Q2 2025.

  • Quarterly results put Current Leases at $13651.0 for Q2 2025, down 47.71% from a year ago — trailing twelve months through Jun 2025 was $13651.0 (down 47.71% YoY), and the annual figure for FY2024 was $26898.0, up 6.17%.
  • Current Leases for Q2 2025 was $13651.0 at Acro Biomedical, down from $18009.0 in the prior quarter.
  • Over the last five years, Current Leases for ACBM hit a ceiling of $26898.0 in Q4 2024 and a floor of $6526.0 in Q3 2023.
  • Median Current Leases over the past 5 years was $24713.0 (2021), compared with a mean of $20904.6.
  • Biggest five-year swings in Current Leases: plummeted 74.37% in 2023 and later soared 306.05% in 2024.
  • Acro Biomedical's Current Leases stood at $24713.0 in 2021, then grew by 4.07% to $25719.0 in 2022, then dropped by 1.49% to $25335.0 in 2023, then grew by 6.17% to $26898.0 in 2024, then tumbled by 49.25% to $13651.0 in 2025.
  • The last three reported values for Current Leases were $13651.0 (Q2 2025), $18009.0 (Q1 2025), and $26898.0 (Q4 2024) per Business Quant data.